Importance of interferons in recovery from mousepox.
PDF (5.2M)
Journal: 1993/July - Journal of Virology
ISSN: 0022-538X
PUBMED: 7685412
Abstract:
Gamma interferon is shown to be critical in recovery of C57BL/6 mice from mousepox. Anti-gamma interferon treatment of mice infected in the footpad with ectromelia virus resulted in enhanced spread to and efficient virus replication in the spleen, lungs, ovaries, and, especially, liver. All treated, infected mice died within a mean of 7 days, 2.5 days earlier than mice with severe combined immunodeficiency that were given a comparable infection. On the other hand, alpha interferon appeared not to have a major role in controlling virus replication in tissues examined, and beta interferon was important for virus clearance in the liver and ovaries but not the spleen. Either anti-alpha, beta interferon or anti-beta interferon antibody therapy resulted in only 25% mortality. Infected control mice survived but showed persistence of ectromelia virus at the site of infection (the footpad) and transient presence of the virus in the spleen, liver, lungs, and ovaries and in the fibroreticular but not lymphoid cells of the draining popliteal lymph node. Depletion of gamma interferon but not alpha and/or beta interferon resulted in a significant reduction in the numbers of splenic T (especially gamma delta-TCR+), B, and Mac-1+ cells, although the proportion of Mac-1+ cells in the spleen increased compared with control values. Depletion of alpha, beta, or gamma interferons did not severely affect the generation of virus-specific cytotoxic T-lymphocyte responses or natural killer cell cytolytic activity. This study, in which a natural virus disease model was used, underscores the crucial importance of gamma interferon in virus clearance at all stages of infection and in all tissues tested except the primary site of infection, where virus clearance appears to be delayed.
Open in
PUBMED | PMC | Google Scholar | Wikipedia
Relations:
Content
Citations
(58)
References
(44)
Diseases
(1)
Chemicals
(2)
Organisms
(4)
Processes
(4)
Anatomy
(3)
Similar articles
Articles by the same authors
Discussion board
J Virol 67(7): 4214-4226
PMID: 7685412

Importance of interferons in recovery from mousepox.

Abstract

Gamma interferon is shown to be critical in recovery of C57BL/6 mice from mousepox. Anti-gamma interferon treatment of mice infected in the footpad with ectromelia virus resulted in enhanced spread to and efficient virus replication in the spleen, lungs, ovaries, and, especially, liver. All treated, infected mice died within a mean of 7 days, 2.5 days earlier than mice with severe combined immunodeficiency that were given a comparable infection. On the other hand, alpha interferon appeared not to have a major role in controlling virus replication in tissues examined, and beta interferon was important for virus clearance in the liver and ovaries but not the spleen. Either anti-alpha, beta interferon or anti-beta interferon antibody therapy resulted in only 25% mortality. Infected control mice survived but showed persistence of ectromelia virus at the site of infection (the footpad) and transient presence of the virus in the spleen, liver, lungs, and ovaries and in the fibroreticular but not lymphoid cells of the draining popliteal lymph node. Depletion of gamma interferon but not alpha and/or beta interferon resulted in a significant reduction in the numbers of splenic T (especially gamma delta-TCR+), B, and Mac-1+ cells, although the proportion of Mac-1+ cells in the spleen increased compared with control values. Depletion of alpha, beta, or gamma interferons did not severely affect the generation of virus-specific cytotoxic T-lymphocyte responses or natural killer cell cytolytic activity. This study, in which a natural virus disease model was used, underscores the crucial importance of gamma interferon in virus clearance at all stages of infection and in all tissues tested except the primary site of infection, where virus clearance appears to be delayed.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (5.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
icon of scanned page 4214
4214
icon of scanned page 4215
4215
icon of scanned page 4216
4216
icon of scanned page 4217
4217
icon of scanned page 4218
4218
icon of scanned page 4219
4219
icon of scanned page 4220
4220
icon of scanned page 4221
4221
icon of scanned page 4222
4222
icon of scanned page 4223
4223
icon of scanned page 4224
4224
icon of scanned page 4225
4225
icon of scanned page 4226
4226

Images in this article

Image
Image
on p.4219
Image
Image
on p.4220
Image
Image
on p.4222
Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Alcamí A, Smith GL. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell. 1992 Oct 2;71(1):153–167. [PubMed] [Google Scholar]
  • Beattie E, Tartaglia J, Paoletti E. Vaccinia virus-encoded eIF-2 alpha homolog abrogates the antiviral effect of interferon. Virology. 1991 Jul;183(1):419–422. [PubMed] [Google Scholar]
  • Buller RM, Holmes KL, Hügin A, Frederickson TN, Morse HC., 3rd Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature. 1987 Jul 2;328(6125):77–79. [PubMed] [Google Scholar]
  • Buller RM, Palumbo GJ. Poxvirus pathogenesis. Microbiol Rev. 1991 Mar;55(1):80–122.[PMC free article] [PubMed] [Google Scholar]
  • Chang HW, Watson JC, Jacobs BL. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4825–4829.[PMC free article] [PubMed] [Google Scholar]
  • Chen W, Drillien R, Spehner D, Buller RM. Restricted replication of ectromelia virus in cell culture correlates with mutations in virus-encoded host range gene. Virology. 1992 Apr;187(2):433–442. [PubMed] [Google Scholar]
  • Davies MV, Elroy-Stein O, Jagus R, Moss B, Kaufman RJ. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J Virol. 1992 Apr;66(4):1943–1950.[PMC free article] [PubMed] [Google Scholar]
  • FENNER F. Mouse-pox; infectious ectromelia of mice; a review. J Immunol. 1949 Dec;63(4):341–373. [PubMed] [Google Scholar]
  • Fleischmann WR, Jr, Fleischmann CM, Fiers W. Potentiation of interferon action by mixtures of recombinant DNA-derived human interferons. Antiviral Res. 1984 Dec;4(6):357–360. [PubMed] [Google Scholar]
  • Jacoby RO, Bhatt PN, Brownstein DG. Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus. Arch Virol. 1989;108(1-2):49–58. [PubMed] [Google Scholar]
  • Jindal S, Young RA. Vaccinia virus infection induces a stress response that leads to association of Hsp70 with viral proteins. J Virol. 1992 Sep;66(9):5357–5362.[PMC free article] [PubMed] [Google Scholar]
  • Karupiah G, Blanden RV, Ramshaw IA. Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J Exp Med. 1990 Nov 1;172(5):1495–1503.[PMC free article] [PubMed] [Google Scholar]
  • Karupiah G, Coupar BE, Andrew ME, Boyle DB, Phillips SM, Müllbacher A, Blanden RV, Ramshaw IA. Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J Immunol. 1990 Jan 1;144(1):290–298. [PubMed] [Google Scholar]
  • Karupiah G, Woodhams CE, Blanden RV, Ramshaw IA. Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice. J Immunol. 1991 Dec 15;147(12):4327–4332. [PubMed] [Google Scholar]
  • Kees U, Blanden RV. A single genetic element in H-2K affects mouse T-cell antiviral function in poxvirus infection. J Exp Med. 1976 Feb 1;143(2):450–455.[PMC free article] [PubMed] [Google Scholar]
  • Klavinskis LS, Geckeler R, Oldstone MB. Cytotoxic T lymphocyte control of acute lymphocytic choriomeningitis virus infection: interferon gamma, but not tumour necrosis factor alpha, displays antiviral activity in vivo. J Gen Virol. 1989 Dec;70(Pt 12):3317–3325. [PubMed] [Google Scholar]
  • Kohonen-Corish MR, King NJ, Woodhams CE, Ramshaw IA. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma. Eur J Immunol. 1990 Jan;20(1):157–161. [PubMed] [Google Scholar]
  • Kotwal GJ, Isaacs SN, McKenzie R, Frank MM, Moss B. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science. 1990 Nov 9;250(4982):827–830. [PubMed] [Google Scholar]
  • Leist TP, Eppler M, Zinkernagel RM. Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice. J Virol. 1989 Jun;63(6):2813–2819.[PMC free article] [PubMed] [Google Scholar]
  • Lucin P, Pavić I, Polić B, Jonjić S, Koszinowski UH. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J Virol. 1992 Apr;66(4):1977–1984.[PMC free article] [PubMed] [Google Scholar]
  • O'Neill HC, Blanden RV. Mechanisms determining innate resistance to ectromelia virus infection in C57BL mice. Infect Immun. 1983 Sep;41(3):1391–1394.[PMC free article] [PubMed] [Google Scholar]
  • O'Neill HC, Blanden RV, O'Neill TJ. H-2-linked control of resistance to ectromelia virus infection in B10 congenic mice. Immunogenetics. 1983;18(3):255–265. [PubMed] [Google Scholar]
  • O'Neill HC, Brenan M. A role for early cytotoxic T cells in resistance to ectromelia virus infection in mice. J Gen Virol. 1987 Oct;68(Pt 10):2669–2673. [PubMed] [Google Scholar]
  • Palumbo GJ, Glasgow WC, Buller RM. Poxvirus-induced alteration of arachidonate metabolism. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):2020–2024.[PMC free article] [PubMed] [Google Scholar]
  • Palumbo GJ, Pickup DJ, Fredrickson TN, McIntyre LJ, Buller RM. Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus. Virology. 1989 Sep;172(1):262–273. [PubMed] [Google Scholar]
  • Pestka S, Langer JA, Zoon KC, Samuel CE. Interferons and their actions. Annu Rev Biochem. 1987;56:727–777. [PubMed] [Google Scholar]
  • Poo WJ, Conrad L, Janeway CA., Jr Receptor-directed focusing of lymphokine release by helper T cells. Nature. 1988 Mar 24;332(6162):378–380. [PubMed] [Google Scholar]
  • Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, Salvesen GS, Pickup DJ. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell. 1992 May 15;69(4):597–604. [PubMed] [Google Scholar]
  • Robertson M. Antigen processing. Proteasomes in the pathway. Nature. 1991 Sep 26;353(6342):300–301. [PubMed] [Google Scholar]
  • Rosa F, Hatat D, Abadie A, Fellous M. Regulation of histocompatibility antigens by interferon. Ann Inst Pasteur Immunol. 1985 Jan-Feb;136C(1):103–119. [PubMed] [Google Scholar]
  • Ruby J, Ramshaw I. The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma. Lymphokine Cytokine Res. 1991 Oct;10(5):353–358. [PubMed] [Google Scholar]
  • Samuel CE. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology. 1991 Jul;183(1):1–11. [PubMed] [Google Scholar]
  • Sibille C, Gould K, Hämmerling G, Townsend A. A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly. Eur J Immunol. 1992 Feb;22(2):433–440. [PubMed] [Google Scholar]
  • Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science. 1990 May 25;248(4958):1019–1023. [PubMed] [Google Scholar]
  • Spitalny GL, Havell EA. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J Exp Med. 1984 May 1;159(5):1560–1565.[PMC free article] [PubMed] [Google Scholar]
  • Springer TA. Adhesion receptors of the immune system. Nature. 1990 Aug 2;346(6283):425–434. [PubMed] [Google Scholar]
  • Tsuru S, Kitani H, Seno M, Abe M, Zinnaka Y, Nomoto K. Mechanism of protection during the early phase of a generalized viral infection. I. Contribution of phagocytes to protection against ectromelia virus. J Gen Virol. 1983 Sep;64(Pt 9):2021–2026. [PubMed] [Google Scholar]
  • Upton C, Macen JL, Schreiber M, McFadden G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology. 1991 Sep;184(1):370–382. [PubMed] [Google Scholar]
  • Upton C, Mossman K, McFadden G. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science. 1992 Nov 20;258(5086):1369–1372. [PubMed] [Google Scholar]
  • Wallace GD, Buller RM. Kinetics of ectromelia virus (mousepox) transmission and clinical response in C57BL/6j, BALB/cByj and AKR/J inbred mice. Lab Anim Sci. 1985 Feb;35(1):41–46. [PubMed] [Google Scholar]
  • Welsh RM. Natural killer cells and interferon. Crit Rev Immunol. 1984;5(1):55–93. [PubMed] [Google Scholar]
  • Wille A, Gessner A, Lother H, Lehmann-Grube F. Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination. Eur J Immunol. 1989 Jul;19(7):1283–1288. [PubMed] [Google Scholar]
  • Yang Y, Waters JB, Früh K, Peterson PA. Proteasomes are regulated by interferon gamma: implications for antigen processing. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4928–4932.[PMC free article] [PubMed] [Google Scholar]
  • Zerial A, Hovanessian AG, Stefanos S, Huygen K, Werner GH, Falcoff E. Synergistic activities of type I (alpha, beta) and type II (gamma) murine interferons. Antiviral Res. 1982 Sep;2(4):227–239. [PubMed] [Google Scholar]
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.
Copyright notice
Abstract
Gamma interferon is shown to be critical in recovery of C57BL/6 mice from mousepox. Anti-gamma interferon treatment of mice infected in the footpad with ectromelia virus resulted in enhanced spread to and efficient virus replication in the spleen, lungs, ovaries, and, especially, liver. All treated, infected mice died within a mean of 7 days, 2.5 days earlier than mice with severe combined immunodeficiency that were given a comparable infection. On the other hand, alpha interferon appeared not to have a major role in controlling virus replication in tissues examined, and beta interferon was important for virus clearance in the liver and ovaries but not the spleen. Either anti-alpha, beta interferon or anti-beta interferon antibody therapy resulted in only 25% mortality. Infected control mice survived but showed persistence of ectromelia virus at the site of infection (the footpad) and transient presence of the virus in the spleen, liver, lungs, and ovaries and in the fibroreticular but not lymphoid cells of the draining popliteal lymph node. Depletion of gamma interferon but not alpha and/or beta interferon resulted in a significant reduction in the numbers of splenic T (especially gamma delta-TCR+), B, and Mac-1+ cells, although the proportion of Mac-1+ cells in the spleen increased compared with control values. Depletion of alpha, beta, or gamma interferons did not severely affect the generation of virus-specific cytotoxic T-lymphocyte responses or natural killer cell cytolytic activity. This study, in which a natural virus disease model was used, underscores the crucial importance of gamma interferon in virus clearance at all stages of infection and in all tissues tested except the primary site of infection, where virus clearance appears to be delayed.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.